SYNBOT
LIVE

Serial Number

79293510

Owner

Synbionik GmbH

Attorney

Vani Moodley

Filing Date

May 12, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SYNBOT Trademark

Serial Number: 79293510 • Registration: 6375285

SYNBOT is a trademark filed by Synbionik GmbH on May 12, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Synbionik GmbH (8 trademarks)

Weismüllerstraße 50

Entity Type: 27

Trademark Details

Filing Date

May 12, 2020

Registration Date

June 8, 2021

Published for Opposition

March 23, 2021

Goods & Services

DNA microarrays; DNA chips; biochip sensors for research or scientific purposes; bioreactor for cell culturing; laboratory equipment, namely, laboratory apparatus and laboratory instruments for use in protein purification, DNA analysis and analysis of blood and biological tissue cultures; laboratory apparatus and instruments, namely, apparatus for sieve tests, the detection of analytes in samples and the identification of the sample type, together with measurement pattern and kits for building and screening of molecular systems, comprised of DNA microarrays, as well as parts for it, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, urine analyzers, immunoassay analyzers, hematology analyzers

Preparations for detecting genetic predispositions for medical purposes; biological implants, namely, a vital processed human or animal connective tissue; biological bone, skin tissue for implantation; biological adjuvants for medical purposes; biological reagents for medical use; biological preparations for the treatment of cancer; mixed biological preparations for medical purposes for the treatment of cancer and the prevention and treatment of infectious diseases; biological tissue cultures for medical purposes; bone growth media consisting of biological materials for medical purposes; human plasma protein being blood plasma; blood plasma; blood components being cord blood, blood, blood plasma for medical purposes; blood substitutes for human, veterinary use; blood protein fractions for medical purposes, namely, for use in cell culture products and diagnostic applications; DNA synthesis inhibitors for medical use; chemical preparations for use in DNA analysis for medical purposes for the treatment of cancer and infectious diseases; cells for medical use; diagnostic medical reagents for medical use in diagnosing inflammatory, infections, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer; diagnostic test kits for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological endocrine, autoimmune and genetic diseases and cancer, comprised of reagents, processing chemicals and transdermal patches; medical diagnostic test kits comprised of medical diagnostic reagents for detecting pathogens in the environment

Chemicals for use in industry; biological preparations for use in industry and science; biological preparations for use in manufacture; biological preparations for use in science; biological preparation for use in cell cultures other than for medical or veterinary use; blood culture media being cell culture media for scientific use; biochemicals, namely precursors for in vitro genetic engineering use; chemical preparations for use in DNA analysis for scientific and research purposes; enzymes for use as biochemical catalysts for scientific and research purposes; biochemicals, namely polypeptides for in vitro research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific use; diagnostic test kits for use in science, comprised of patch preparations in the nature of diagnostic reagents; diagnostic test kits for scientific use, comprised of reagents, processing chemicals; biochemicals for in vitro and in vivo use in industry and science; molecular biological products in the nature of reagents for use in industry and science; plasmids for use in industry and science; chromosomes being DNA molecules, DNA polymerase for use in industry and science; Diagnostic test kits for use in science, comprised of patch preparations being diagnostic reagents

Medical and health assessment services relating to naked DNA, genetics and genetic testing for medical purposes; genetic counselling; blood bank services; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; medical diagnostic services being the execution of tests and analysis; execution of medical tests for diagnostic or treatment purposes

Genetic research; genetic fingerprinting for scientific or medical research purposes; scientific research relating to genetics; scientific research in the field of genetics and genetic engineering; biological laboratory services; biological cloning services; biological research, clinical research and medical research, namely, conducting clinical trials for others as well as medical and clinical research in the field of cancer and infectious diseases; scientific laboratory services, namely, services of a chemical and/or biological laboratory; blood analysis services; genetic engineering services; DNA screening for scientific research purposes; research and development in the field of microorganisms and cells; scientific services relating to the isolation and cultivation of human tissues and cells; research and development services for third parties in the fields of diagnostic chemicals, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental testing processes and industrial quality control processes; chemical sieve analysis; scientific and technological services, namely, research and design services in the field of diagnostic chemicals; industrial analysis in the nature of analysis of industrial fluids; industrial research in the field of diagnostic chemicals; services of an industrial designer; quality control for others; authentication services in the field of diagnostic chemicals, measuring apparatus; design and development of computer hardware and software; scientific and product research in the area of textile dyes; product , scientific, and biomedical research, in the area of textile dyes consisting of bacteria

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 28, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 28, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 8, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 8, 2021 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 30, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2021 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 23, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 22, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 3, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 3, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 3, 2021 NONP
ASSIGNED TO LIE
Feb 17, 2021 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2021 TROA
REFUSAL PROCESSED BY IB
Nov 2, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 15, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 15, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 23, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 22, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 22, 2020 MAFR
ASSIGNED TO EXAMINER
Sep 18, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 17, 2020 REPR